Global, Regional, and National Burdens of Leukemia from 1990 to 2017: a Systematic Analysis of the Global Burden of Disease 2017 Study

Xiangjie Lin,Jinghan Wang,Xin Huang,Huafeng Wang,Fenglin Li,Wenle Ye,Shujuan Huang,Jiajia Pan,Qing Ling,Wenwen Wei,Shihui Mao,Yu Qian,Jie Jin,Jiansong Huang
DOI: https://doi.org/10.18632/aging.202809
2021-01-01
Aging
Abstract:We described the spatial and temporal trends of the annual leukemia incidence, prevalence, mortality, and disability-adjusted life years (DALYs) from 1990 to 2017. Leukemia case numbers and age-standardized rates (ASRs) were extracted from the Global Burden of Disease (GBD) study 2017. The estimated annual percentage change (EAPC) in the ASR was calculated using a generalized linear model with a Gaussian distribution. The risk factors for death and DALYs due to leukemia were estimated within the comparative risk assessment framework of the GBD study. Globally, the prevalence, age-standardized prevalence rate (ASPR), and EAPC in leukemia cases in 2017 were 2.43 (95% uncertainty interval (UI) 2.19 to 2.59) million, 32.26 (95% UI 29.02 to 34.61), and 0.22% (95% CI 0.13 to 0.31, P<0.01), respectively, during 1990-2017. The trends of the age-standardized incidence, deaths, and DALY rate all significantly decreased globally. The burden of leukemia was higher in males than in female. An increasing leukemia burden was found in high-middle-sociodemographic index (SDI) countries and territories. The burden of leukemia tended to be lower in high-SDI regions than that in lower SDI regions. The rapid increases in the prevalent cases and prevalence rate of leukemia is urgent to be solved in the future.
What problem does this paper attempt to address?